Analysis of a peptide hormone–receptor interaction in the yeast two-hybrid system
- Research Division, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, MA 02215
-
Communicated by Arnold L. Demain, Massachusetts Institute of Technology, Cambridge, MA (received for review April 25, 1997)
Abstract
Interaction between a peptide hormone and extracellular domains of its receptor is a crucial step for initiation of hormone action. We have developed a modification of the yeast two-hybrid system to study this interaction and have used it to characterize the interaction of insulin-like growth factor 1 (IGF-1) with its receptor by using GAL4 transcriptional regulation with a β-galactosidase assay as readout. In this system, IGF-1 and proIGF-1 bound to the cysteine-rich domain, extracellular domain, or entire IGF-1 proreceptor. This interaction was specific. Thus, proinsulin showed no significant interaction with the IGF-1 receptor, while a chimeric proinsulin containing the C-peptide of IGF-1 had an intermediate interaction, consistent with its affinity for the IGF-1 receptor. Over 2000 IGF-1 mutants were generated by PCR and screened for interaction with the color assay. About 40% showed a strong interaction, 20% showed an intermediate interaction, and 40% give little or no signal. Of 50 mutants that were sequenced, several (Leu-5 → His, Glu-9 → Val, Arg-37 → Gly, and Met-59 → Leu) appeared to enhance receptor association, others resulted in weaker receptor interaction (Tyr-31 → Phe and Ile-43 → Phe), and two gave no detectable signal (Leu-14 → Arg and Glu-46 → Ala). Using PCR-based mutagenesis with proinsulin, we also identified a gain of function mutant (proinsulin Leu-17 → Pro) that allowed for a strong IGF-1–receptor interaction. These data demonstrate that the specificity of the interaction between a hormone and its receptor can be characterized with high efficiency in the two-hybrid system and that novel hormone analogues may be found by this method.
Footnotes
-
↵ * To whom reprint requests should be addressed at: Joslin Diabetes Center, Research Division, One Joslin Place, Boston, MA 02215. e-mail: kahnr{at}joslab.harvard.edu.
- ABBREVIATIONS:
- IGF-1,
- insulin-like growth factor 1;
- GAL4DB,
- GAL4 DNA-binding domain;
- GAL4AD,
- GAL4 activation domain;
- IRR,
- insulin receptor-related receptor;
- InIGF,
- chimeric molecule with the C-peptide of IGF-1 inserted into human insulin;
- IGF1R,
- full-length IGF-1 proreceptor
- Copyright © 1997, The National Academy of Sciences of the USA





